This doctor won’t prescribe Addyi, the “female Viagra.” Here’s why.
Addyi (flibanserin), the drug to increase female libido had a timid entry into the market with very few prescriptions considering the “hype.” Bloomberg Business reported 227 prescriptions in the first month. That’s a pittance considering Valeant paid $1 billion for the drug.
I am unlikely to help Valeant recoup their investment, because the more I read about this drug, the worse it looks. Here’s why:
It barely works
One of the study endpoints (meaning …
This doctor won’t prescribe Addyi, the “female Viagra.” Here’s why.










![Politics and fear have replaced science in U.S. pain management [PODCAST]](https://kevinmd.com/wp-content/uploads/11c2db8f-2b20-4a4d-81cc-083ae0f47d6e-190x100.jpeg)




![Why hospital systems fail to notice the human behind the bill [PODCAST]](https://kevinmd.com/wp-content/uploads/ea65fd1d-d282-4c46-a750-620a3c3bb42f-190x100.jpeg)


